According to recent filings covering the 90 days ending January 10, 2026, the three most significant insider holders at Galectin Therapeutics are Director Richard E Uihlein (10.30Mn shares), TenPercentOwner James C Czirr (5.92Mn shares), TenPercentOwner Fund, L.P. 10x (5.67Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Richard E Uihlein | 10,301,271 | 27 Jan, 2025 | |
| James C Czirr | 5,922,207 | 25 Apr, 2024 | |
| Fund, L.P. 10x | 5,670,138 | 08 Dec, 2025 | |
| Joel Lewis | President And Ceo | 834,592 | 06 Jan, 2026 |
| Kevin D Freeman | 135,269 | 23 Dec, 2025 | |
| Kary Eldred | 65,382 | 23 Dec, 2025 | |
| Richard A. Jr. Zordani | 44,083 | 26 Dec, 2024 | |
| Jack W Callicutt | Chief Financial Officer | 7,614 | 06 Jan, 2026 |
| Harold H. Shlevin | 6,500 | 19 Dec, 2025 | |
| Elissa J. Schwartz | 1,000 | 24 Jan, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Jan, 2026 | Jack W Callicutt | Common Stock | D | 20,354 | $3.67 | 7,614 | D | S |
| 06 Jan, 2026 | Joel Lewis | Common Stock | D | 37,698 | $3.58 | 832,592 | D | S |
| 06 Jan, 2026 | Khurram Jamil | Common Stock | D | 21,446 | $3.65 | 0 | D | S |
| 05 Jan, 2026 | Jack W Callicutt | Common Stock | D | 25,732 | $3.90 | 27,968 | D | S |
| 05 Jan, 2026 | Joel Lewis | Common Stock | D | 27,731 | $3.91 | 870,290 | D | S |
| 05 Jan, 2026 | Khurram Jamil | Common stock | D | 25,499 | $3.90 | 21,446 | D | S |
| 02 Jan, 2026 | Jack W Callicutt | Common Stock | D | 13,914 | $4.20 | 53,700 | D | S |
| 02 Jan, 2026 | Jack W Callicutt | Common Stock | A | 60,000 | $0.00 | 67,614 | D | M |
| 02 Jan, 2026 | Joel Lewis | Common Stock | A | 84,000 | $0.00 | 916,592 | D | M |
| 02 Jan, 2026 | Joel Lewis | Common Stock | D | 18,571 | $4.20 | 898,021 | D | S |
| 02 Jan, 2026 | Khurram Jamil | Common Stock | D | 13,055 | $4.20 | 46,945 | D | S |
| 02 Jan, 2026 | Khurram Jamil | Common Stock | A | 60,000 | $0.00 | 60,000 | D | M |
| 31 Dec, 2025 | Khurram Jamil | Common Stock | A | 8,125 | $1.23 | 8,125 | D | M |
| 31 Dec, 2025 | Khurram Jamil | Common Stock | D | 8,125 | $4.07 | 0 | D | S |
| 23 Dec, 2025 | Kevin D Freeman | Common Stock | A | 5,500 | $3.55 | 55,269 | D | P |
| 23 Dec, 2025 | Kevin D Freeman | - | - | 55,269 | D | |||
| 23 Dec, 2025 | Kevin D Freeman | Common Stock | A | 5,500 | $3.55 | 55,269 | D | P |
| 23 Dec, 2025 | Kevin D Freeman | Common Stock | A | 5,500 | $3.55 | 55,269 | D | P |
| 23 Dec, 2025 | Kary Eldred | Common Stock | A | 700 | $3.73 | 65,382 | D | P |
| 23 Dec, 2025 | Kary Eldred | Common Stock | A | 700 | $3.73 | 65,382 | D | P |